Protagonist Therapeutics Inc (PTGX)
Operating Income Growth
143.34%
TTM · Period ending:
PTGX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported143.34%period ending
Latest reported143.34%period ending
PTGX TTM Operating Income YoY % (-120.81% → 143.34%)
Year-over-year change
High-resolution chart · PNG
PTGX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 143.335% | |
| -623.3066% | |
| -162.5396% | |
| -87.2525% | |
| -84.2511% | |
| -81.6893% | |
| 369.9814% | |
| 197.3208% | |
| 203.4274% | |
| 201.6372% | |
| 28.7129% | |
| -15.3977% | |
| -9.5226% | |
| -18.1273% | |
| -3.6514% | |
| -23.3274% | |
| -64.893% | |
| -79.8881% | |
| -96.4551% | |
| -70.928% | |
| -12.6071% | |
| 19.5512% | |
| 19.8768% | |
| 19.9011% | |
| -2.1508% | |
| -75.7517% | |
| -90.4966% | |
| -158.92% | |
| -172.9325% | |
| -52.8522% | |
| -11.5365% | |
| 33.6624% | |
| 45.8458% | |
| 20.1659% | |
| -16.0136% | |
| -74.271% | |
| -107.0531% | |
| -108.4043% | |
| -120.8057% |